|
Age mean (SD), years
|
40.7 (9.8)
|
40.6 (9.4)
|
40.7 (10.2)
|
|
Gender, N (%)
|
|
- Male
|
127 (75.1)
|
61 (72.6)
|
66 (77.6)
|
|
Patients > 50% medication adherence, N (%)
|
135 (79.9)
|
68 (80.0)
|
67 (79.8)
|
|
Place of treatment, N (%)
|
|
- The Hague
|
46 (27.2)
|
18 (21.4)
|
18 (21.2)
|
|
- Rotterdam
|
123 (72.8)
|
66 (78.6)
|
67 (78.8)
|
|
Substance use disorder, N (%)
|
94 (55.6)
|
48 (57.1)
|
46 (54.1)
|
|
Antipsychotic Medication side effects, mean (SD)
|
4,8 (4,0)
|
5,3 (4,0)
|
4,3 (3,9)
|
|
Illness insight; median (interquartile range) (range 1–7)
|
3 (1–4)
|
3 (1–4)
|
2 (1–4)
|
|
Health of the Nation Outcome Scales (HoNOS), N (%)
|
|
- No motivational problems
|
136 (80.4)
|
66 (78.6)
|
70 (82.3)
|
|
- Severe motivational problems
|
28 (16.6)
|
17 (20.2)
|
11 (12.9)
|
|
- Item missing
|
5 (3.0)
|
1 (1.2)
|
4 (4.8)
|
|
Treatment Entry Questionnaire, (TEQ) N (%)
|
85 (50.3)
|
42 (50.0)
|
43 (50.6)
|
|
- External motivation; mean (SD), (range 12–84)
|
18.4 (7.8)
|
17.6 (8.1)
|
19.0 (7.6)
|
|
- Introjected motivation; mean (SD), (range 6–42)
|
18.7 (10.6)
|
19.3 (9.4)
|
18.2 (9.4)
|
|
- Identified motivation; mean (SD), (range 9–63)
|
28.5 (10.0)
|
28.6 (10.9)
|
28.5 (9.2)
|
